HEALTH
Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes – Medical Xpress
- Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes Medical Xpress
- Age Affects Efficacy of Popular Diabetes Drugs Medscape
- SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease Medpage Today
- Top in endocrinology: SGLT2s vs. GLP-1s in older adults; weight cycling in type 1 diabetes Healio
- US FDA-approved diabetes drug shows promise against heart attacks, strokes: Study Gulf News
Source link
